- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05880251
Operant Conditioning of Sensory Brain Responses to Reduce Phantom Limb Pain in People With Limb Amputation (OCS-PLP)
Operant Conditioning of Sensory Evoked Potentials to Reduce Phantom Limb Pain
Study Overview
Status
Conditions
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
New York
-
Albany, New York, United States, 12208-3410
- Albany VA Medical Center Samuel S. Stratton, Albany, NY
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- An upper (or lower limb) amputation more than 6 months ago, that has produced a moderate to severe hand/arm (or foot/leg) phantom limb pain,
- Male or female age 18 years or older,
- Medical clearance to participate,
- Reasonable expectation that ongoing medications, if any, will be maintained without change for at least 4 months from the start of the study,
- Able to provide informed consent and to understand the study instructions,
- Able to participate in the specific study procedures.
Exclusion Criteria:
- Presence of other medically unstable and/or infectious condition (e.g., uncontrolled diabetes with recent weight loss, diabetic coma, frequent insulin reactions),
- A cardiac condition (e.g., history of myocardial infarction or congestive heart failure),
- Cognitive and/or attention difficulties affecting participant's ability to follow study directions,
- Known skin disorders or damaged skin at the anticipated at the scalp for EEG recording (e.g., unhealed wounds, broken skin).
- Metal implants above the chest
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention Group
Intervention group receives peripheral stimulation with realtime operant conditioning feedback training.
|
This is a training intervention to strengthen the weakened sensorimotor responses and reduce pain, after a limb amputation.
Non-painful peripheral stimulation will be applied to elicit a response.
|
|
Experimental: Control Group
Control group receives peripheral stimulation but without operant conditioning feedback.
|
This is a control intervention in which the non-painful peripheral stimulation will be applied, same as the operant conditioning group, but no training feedback will be provided.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Pain as Measured by the Short form-McGill Pain Questionnaire (SF-MPQ)
Time Frame: Baseline, end of training (session 20) i.e. approximately 10 weeks from baseline, follow-up at 3-months after training ends, follow-up at 6-months after training ends
|
The Sf-MPQ assesses the pain quality in the sensory (11 items) and affective (4 items) dimensions.
Each item is rated on an intensity scale of 0 (none) to 3 (severe).
Total score is obtained by summing the scores for all items and the range is 0 (no pain) to 45 (severe pain).
|
Baseline, end of training (session 20) i.e. approximately 10 weeks from baseline, follow-up at 3-months after training ends, follow-up at 6-months after training ends
|
|
Change in Somatosensory Evoked Potential (SSEP) Latency as Measured by a Tactile Event Related Potential Test
Time Frame: Baseline, end of training (session 20) i.e. approximately 10 weeks from baseline, follow-up at 3-months after training ends, follow-up at 6-months after training ends
|
The evoked response to tactile stimuli will be captured with 64 channel non-invasive scalp electroencephalography (EEG) electrodes placed on the scalp.
SSEP will be assessed at the sensorimotor cortex contralateral to the amputated limb.
A reduction in latency will indicate improvement in the sensorimotor cortical response.
|
Baseline, end of training (session 20) i.e. approximately 10 weeks from baseline, follow-up at 3-months after training ends, follow-up at 6-months after training ends
|
|
Change in Evoked Potential (EP) Amplitude and threshhold
Time Frame: Baseline, end of training (session 20) i.e. approximately 10 weeks from baseline, follow-up at 3-months after training ends, follow-up at 6-months after training ends
|
The evoked response to tactile stimuli will be captured in one of two ways 1) EMG and Reflex evoke responses from cutaneous nerve on the residual Limb and 2) With 64 channel non-invasive scalp electroencephalography (EEG) electrodes placed on the scalp.
SSEP will be assessed at the sensorimotor cortex contralateral to the amputated limb.
An increase in amplitude will indicate improvement in the sensorimotor response and tolerance.
|
Baseline, end of training (session 20) i.e. approximately 10 weeks from baseline, follow-up at 3-months after training ends, follow-up at 6-months after training ends
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Impact of Pain on Quality of Life as Measured by the West Haven-Yale Multidimensional Pain Inventory (WHYMPI)
Time Frame: Baseline, end of training (session 20) i.e. approximately 10 weeks from baseline, follow-up at 3-months after training ends, follow-up at 6-months after training ends
|
This is a 52-item inventory with 12 subscales over 3 domains. Each item is scored on a 0-6 scale. Scores for each subscale are obtained by taking the mean of the scores of all items in that subscale. Higher scores indicate more severity in that subscale. Part I includes five scales designed to measure important dimensions of the chronic pain experience; Part II assesses patients' perceptions of the degree to which spouses or significant others display Solicitous, Distracting or Negative responses to their pain behaviors and complaints. Part III assesses patients' report of the frequency with which they engage in four categories of common everyday activities; Household Chores, Outdoor Work, Activities Away from Home, and Social Activities. |
Baseline, end of training (session 20) i.e. approximately 10 weeks from baseline, follow-up at 3-months after training ends, follow-up at 6-months after training ends
|
Collaborators and Investigators
Investigators
- Principal Investigator: Jodi A Brangaccio, PT, Albany VA Medical Center Samuel S. Stratton, Albany, NY
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Pain
- Neurologic Manifestations
- Nervous System Diseases
- Postoperative Complications
- Pathologic Processes
- Neurobehavioral Manifestations
- Perceptual Disorders
- Pain, Postoperative
- Pathological Conditions, Signs and Symptoms
- Signs and Symptoms
- Chronic Pain
- Phantom Limb
- Investigative Techniques
- Epidemiologic Research Design
- Epidemiologic Methods
- Research Design
- Methods
- Control Groups
Other Study ID Numbers
- F4410-P
- 1I21RX004410-01A1 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.